Physician profile
Jack Zackey
NPI 1750887386
$2,711.72
in general payments reported to CMS, 2019-2025
21 companies · $151 in 2025
The $151 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $164 · 2023: $533 · 2024: $1,864 · 2025: $151.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,302 · Food and Beverage: $957 · Education: $264 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $25.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,301.61 |
| Food and Beverage | $957.24 |
| Education | $263.99 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $25.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $1,452.84 | 2024 | Axonics, Bulkamid |
| Astellas Pharma US INC | $399.99 | 2023-2025 | Veozah, Myrbetriq |
| Amgen INC. | $116.18 | 2022-2024 | Prolia, Evenity |
| Boston Scientific Corporation | $102.03 | 2023 | Solyx Sis System |
| Medtronic, INC. | $82.72 | 2024-2025 | Interstim |
| Novo Nordisk INC | $76.85 | 2022-2024 | Wegovy |
| Hologic Sales and Service, LLC | $73.93 | 2022-2023 | Acessa Provu System, Coolseal Generator, Novasure |
| Sage Therapeutics, LLC | $63.43 | 2025 | Zurzuvae |
| Pfizer INC. | $53.51 | 2022-2025 | |
| Sumitomo Pharma America, INC. | $41.07 | 2023-2024 | Myfembree |
| Organon LLC | $35.21 | 2022-2024 | |
| Monaghan Medical Corporation | $33.69 | 2024 | Aerobika |
| Exeltis, USA INC. | $29.61 | 2023-2024 | Slynd |
| Becton, Dickinson and Company | $25.00 | 2024 | |
| Northgate Technologies, INC. | $24.64 | 2024 | Stimsite |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shield Therapeutics INC | $24.40 | 2024 | |
| Supernus Pharmaceuticals, INC. | $16.55 | 2025 | Qelbree |
| Coopersurgical, INC. | $16.52 | 2025 | Advincula Delineator Uterine Manipulator |
| Myovant Sciences INC. | $15.14 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.67 | 2022 | |
| Minerva Surgical, INC | $13.74 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jack Zackey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.